| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 05/15/2001 | US6232074 Functional gene array in yeast |
| 05/15/2001 | US6232071 Tenascin-C nucleic acid ligands |
| 05/15/2001 | US6232070 Pharmacological targeting of mRNA cap formation |
| 05/15/2001 | US6232066 High throughput assay system |
| 05/15/2001 | US6232064 Fibrosis and atherosclerosis determination |
| 05/15/2001 | US6232063 Detection of homozygousity or heterozygousity in mutations; amplification of nucleic acids and primer pairs using polymerase |
| 05/15/2001 | US6232061 Detecting hybridization signals with probes; genetic engineering; identifying dna sequences that code for evolutionary conserved amino acid sequences |
| 05/15/2001 | US6231870 Oral administration of pneumoccal antigens |
| 05/15/2001 | US6231868 Method for generating nonpathogenic infections birnavirus from synthetic RNA transcripts |
| 05/15/2001 | US6231864 Strategically modified hepatitis B core proteins and their derivatives |
| 05/15/2001 | US6231863 DNA sequences, molecules, vectors and vaccines for feline calicivirus disease and methods for producing and using same |
| 05/15/2001 | US6231861 Plasmodium vivax blood stage antigens, antibodies, and diagnostic assays |
| 05/15/2001 | US6231854 Methioninase formulations and use in diagnostic methods |
| 05/15/2001 | US6231812 Method and apparatus for indentifying, classifying, or quantifying protein sequences in a sample without sequencing |
| 05/15/2001 | CA2083948C Glyphosate tolerant plants |
| 05/15/2001 | CA2078858C Expression of heterologous protein in yeast |
| 05/15/2001 | CA2041638C Recombinant polynucleotide constructs suitable for providing secretion of pai-2 |
| 05/15/2001 | CA1341234C Recombinant fowlpox virus |
| 05/15/2001 | CA1341231C Primary biliary cirrhosis autoantigen |
| 05/15/2001 | CA1341230C Amino acid sequence of l-phenylalanine ammonia-lyase, structural gene thereof, novel dna sequence containing same, novel recombinant dna plasmid containing same transformant formed therewith, and process for the production of l-phenylalanine by using same |
| 05/15/2001 | CA1341229C Procoagulant proteins derived from factor viii: c |
| 05/15/2001 | CA1341228C Expression of protein c |
| 05/15/2001 | CA1341227C Human transforming growth factor alpha |
| 05/12/2001 | CA2287525A1 Methods for production and purification of nucleic acid molecules |
| 05/10/2001 | WO2001033221A1 Axor35, a g-protein coupled receptor |
| 05/10/2001 | WO2001033199A2 Universal fluorescent sensors |
| 05/10/2001 | WO2001032935A2 Molecular microarrays and methods for production and use thereof |
| 05/10/2001 | WO2001032930A1 Methods and apparatuses for analyzing polynucleotide sequences |
| 05/10/2001 | WO2001032927A2 Tissue specific genes of diagnostic import |
| 05/10/2001 | WO2001032926A2 Differentially expressed genes involved in angiogenesis, the polypeptides encoded thereby, and methods of using the same |
| 05/10/2001 | WO2001032925A1 Modulation of neuroendocrine differentiation by protein 25.1 |
| 05/10/2001 | WO2001032923A1 Antisense inhibition of pi3 kinase p55 gamma expression |
| 05/10/2001 | WO2001032922A2 Methods for detection of a target nucleic acid sequence |
| 05/10/2001 | WO2001032921A2 Method of diagnosing rheumatoid arthritis |
| 05/10/2001 | WO2001032918A1 Specific peptide substrate for human yak1, yak3a, and yak3b and yeast yak1 protein kinases |
| 05/10/2001 | WO2001032910A2 27 human secreted proteins |
| 05/10/2001 | WO2001032904A2 Method for enhancing secretion of beta-lactam compounds |
| 05/10/2001 | WO2001032901A1 Expression vectors, transfection systems, and method of use thereof |
| 05/10/2001 | WO2001032900A1 Method for transfer of molecular substances with prokaryontic nucleic acid-binding proteins |
| 05/10/2001 | WO2001032899A1 Gene transfer method |
| 05/10/2001 | WO2001032898A2 Recombinant sendai virus vector for introducing exogenous genes to airway epithelia |
| 05/10/2001 | WO2001032897A2 A high level, stable, constitutive promoter element for plants |
| 05/10/2001 | WO2001032896A1 Protein expression systems for non-pathogenic <i>kinetoplastidae</i> |
| 05/10/2001 | WO2001032895A1 Recombinant yeast strain for expressing human lactoferrin, n-lobe lactoferrin, c-lobe lactoferrin and process for preparation recombinant human lactoferrin, n-lobe lactoferrin, c-lobe lactoferrin using the same |
| 05/10/2001 | WO2001032894A1 Cell surface display of proteins by recombinant host cells |
| 05/10/2001 | WO2001032893A1 Recombinant therapeutic fusion proteins |
| 05/10/2001 | WO2001032892A1 Polynucleotide encoding mouse histidine decarboxylase |
| 05/10/2001 | WO2001032891A2 Human lipase |
| 05/10/2001 | WO2001032890A1 L-pantolactone-hydrolase and a method for producing d-pantolactone |
| 05/10/2001 | WO2001032889A1 Murine serine/threonine kinase, yak3 |
| 05/10/2001 | WO2001032888A2 Human transferase molecules |
| 05/10/2001 | WO2001032887A1 Compositions and methods utilizing dna polymerases |
| 05/10/2001 | WO2001032886A2 Starch branching enzymes |
| 05/10/2001 | WO2001032883A2 Expression of the osa gene in transgenic plants confers resistance to agrobacterium transformation and crown gall disease |
| 05/10/2001 | WO2001032882A2 Nucleic acids and proteins from group b streptococcus |
| 05/10/2001 | WO2001032881A1 PHOTOSENSITIVITY GENE Hd1 OF PLANT AND UTILIZATION THEREOF |
| 05/10/2001 | WO2001032880A1 Photosensitivity gene of plant and utilization thereof |
| 05/10/2001 | WO2001032879A2 Method for producing recombinant interleucin-8 and interleucin-8 muteins |
| 05/10/2001 | WO2001032878A2 A novel polypeptide hormone phosphatonin |
| 05/10/2001 | WO2001032877A2 CpG RECEPTOR (CpG-R) AND METHODS RELATING THERETO |
| 05/10/2001 | WO2001032876A2 Compositions and methods for determining interactions of mitochondrial components, and for identifying agents that alter such interactions |
| 05/10/2001 | WO2001032875A1 Torsin c nucleic acids and polypeptides |
| 05/10/2001 | WO2001032874A2 Polypeptides and nucleic acids encoding same |
| 05/10/2001 | WO2001032873A1 Insulin-responsive sequence dna binding protein-1' (irsdbp-1), gene encoding it and uses thereof |
| 05/10/2001 | WO2001032872A2 Twik potassium channel molecules and uses therefor |
| 05/10/2001 | WO2001032870A1 Novel human melastatin-like proteins and polynucleotides encoding the same |
| 05/10/2001 | WO2001032869A1 HUMAN PROTEINS BINDING TO HUMAN TYROSINE KINASE Hck AND GENES ENCODING THE SAME |
| 05/10/2001 | WO2001032868A1 Apm1 biallelic markers and uses thereof |
| 05/10/2001 | WO2001032867A1 Polypeptides with expanded primary signalling motifs |
| 05/10/2001 | WO2001032866A2 Hybrid adaptor receptors |
| 05/10/2001 | WO2001032865A1 Human gpr27-like g-protein coupled receptor polypeptide and polynucleotide sequences |
| 05/10/2001 | WO2001032864A2 Gpcr-kd5 polypeptides and dna sequences thereof |
| 05/10/2001 | WO2001032863A1 A novel polypeptide, a human apoptosis associated protein 12 and the polynucleotide encoding the polypeptide |
| 05/10/2001 | WO2001032862A1 A novel polypeptide, a human s4 ribosome protein 20 and the polynucleotide encoding the polypeptide |
| 05/10/2001 | WO2001032861A1 Tumour suppressor genes from chromosome 16 |
| 05/10/2001 | WO2001032858A1 A high throughput screening (hts) method |
| 05/10/2001 | WO2001032857A1 Methylation of unstable sequences |
| 05/10/2001 | WO2001032856A2 Seed-preferred promoter from barley |
| 05/10/2001 | WO2001032855A1 Transgenic animal production using lopu-derived oocytes |
| 05/10/2001 | WO2001032854A1 Production of transgenic animals using nuclear transfer and oocytes recovered by lopu |
| 05/10/2001 | WO2001032852A2 Method for directed packaging of molecular substances in protein shells |
| 05/10/2001 | WO2001032851A2 Modular transport systems for molecular substances and production and use thereof |
| 05/10/2001 | WO2001032849A2 Inhibitors of vegetable cystathionin gamma synthase |
| 05/10/2001 | WO2001032846A1 Catalytic nucleic acid sequences |
| 05/10/2001 | WO2001032845A2 Methods for the preparation of (lipo)peptide synthetases and (lipo)peptides produced therewith |
| 05/10/2001 | WO2001032844A1 Microtiter plate (mtp) based high throughput screening (hts) assays |
| 05/10/2001 | WO2001032838A2 Methods for improving viral vector titers and reducing cell death in cell cultures |
| 05/10/2001 | WO2001032837A1 19 human secreted proteins |
| 05/10/2001 | WO2001032834A1 A method of screening cell populations |
| 05/10/2001 | WO2001032832A2 Antisense inhibition of nucleolin expression |
| 05/10/2001 | WO2001032831A2 Screening and use of agents which block or activate intein splicing utilizing natural or homologous exteins |
| 05/10/2001 | WO2001032829A2 Methods to screen microorganisms or gene libraries for products secreted from a cell |
| 05/10/2001 | WO2001032783A1 Water-soluble rhodamine dyes and conjugates thereof |
| 05/10/2001 | WO2001032714A1 Recombinant fusion molecules |
| 05/10/2001 | WO2001032712A2 Antibody diversity generation |
| 05/10/2001 | WO2001032711A2 Adeno-associated virus aav rep78 major regulatory protein, mutants thereof and uses thereof |
| 05/10/2001 | WO2001032710A1 Dog and rabbit motilin receptor orthologs |
| 05/10/2001 | WO2001032709A2 Polypeptides with non-natural primary signalling motifs |
| 05/10/2001 | WO2001032707A1 Human semaphorin |
| 05/10/2001 | WO2001032706A2 Novel human transporter proteins and polynucleotides encoding the same |